[Subtle, temporary, homonymous visual field defect--fatal causes?].
Müller
M
M
Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck. mayamueller@gmx.de
Paulsen
J
J
Hoerauf
H
H
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D054092:Foramen Ovale, Patent / Q000150:complications* / Q000175:diagnosis; D006423:Hemianopsia; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010644:Phenprocoumon / Q000008:administration & dosage / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012607:Scotoma / Q000175:diagnosis*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014794:Visual Fields
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D010644:Phenprocoumon; D001241:Aspirin